Profile
Rolf Magnus Björsne is currently the Chief Executive Officer at AstraZeneca BioVentureHub AB, Chairman at Termino C 2915 AB, and Director at SwedenBIO Service AB. He previously worked as a Director at Beactica Therapeutics AB from 2014 to 2018 and as an Independent Director at Isofol Medical AB from 2018 to 2023.
Björsne holds a doctorate from the University of Stockholm and an MBA from Henley Management College.
Rolf Magnus Björsne active positions
| Companies | Position | Start |
|---|---|---|
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services Provides educational services | Director/Board Member | - |
Termino C 2915 AB | Chairman | - |
AstraZeneca BioVentureHub AB | Chief Executive Officer | - |
Former positions of Rolf Magnus Björsne
| Companies | Position | End |
|---|---|---|
| ISOFOL MEDICAL AB | Director/Board Member | 01/02/2023 |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Operates as a drug discovery company | Director/Board Member | 01/01/2018 |
Training of Rolf Magnus Björsne
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Henley Management College
Henley Management College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Operates as a drug discovery company | Distribution Services |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services Provides educational services | Commercial Services |
Isofol Medical AB
Isofol Medical AB Pharmaceuticals: MajorHealth Technology Provides novel folate-based pharmaceutical products | Health Technology |
Termino C 2915 AB | |
AstraZeneca BioVentureHub AB |
- Stock Market
- Insiders
- Rolf Magnus Björsne
















